News
PFA is a newer Afib ablation modality touted as reducing the risk of damaging nearby collateral structures, compared with ...
Patients with a high probability of HFpEF may experience greater benefits from atrial fibrillation ablation than those with a ...
The continued success of abelacimab throughout the AZALEA-TIMI 71 trials helps draw the drug closer to FDA approval, stated ...
A new study published in the Journal of the American College of Cardiology showed that the patients with atrial fibrillation ...
Sky Labs, a health-tech startup based in South Korea, announced that its ring-shaped smart medical device, CART-I (Cardio ...
You may be able to lower your risk for developing heart rhythm abnormalities by speeding up your walking pace. That’s according to a large new study published Tuesday in the journal Heart, which found ...
Catheter Ablation Devices for Atrial Fibrillation Market 2035, Driven by advanced devices, better clinical outcomes, and rising regulatory approvals.
A lower apixaban dose is indicated in patients with an eGFR less than 30 mL/min/1.73 m2, regardless of dialysis status.
The study was published online in JAMA Neurology on March 31, 2025.
‘Training on synthetic fibrosis images achieved a 0.943 ROC-AUC—nearly matching real MRI data (0.952). AI is transforming heart treatment.#aiinhealthcare #medindia ’ Existing methods like ...
Recent advancements in artificial intelligence have led to the development of a groundbreaking tool designed to assist in the management of atrial fibrillation (AF) by creating synthetic models of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results